News about Market

Entod Pharmaceuticals Partners with DPGU and BNCP for Research and Innovation

Entod Pharmaceuticals is working with DPGU and BNCP to support pharmaceutical research, formulation development and industry-relevant skills.

Market | 16/10/2026 | By News Bureau

Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics

Mankind Pharma enters into an agreement to acquire a majority stake in Belgium-based Armed Cell Therapeutics, which is developing next-generation CAR-T cancer therapies.

Market | 16/10/2026 | By News Bureau

Agilent to Acquire Proscia to Advance AI Digital Pathology

Agilent has planned to acquire Proscia to expand its AI-enabled digital pathology portfolio, combining instruments, reagents and software in a high-growth market.

Market | 16/10/2026 | By News Bureau

Viking Therapeutics Launches Phase 3 Trial of Oral VK2735

Viking Therapeutics has launched phase 3 trials of oral VK2735 to evaluate its efficacy in adults with obesity, with and without Type 2 Diabetes (T2D).

Market | 15/10/2026 | By News Bureau

Teiko, University of Utah Collaborate on AML MRD Testing

Teiko and University of Utah partners are developing immune profiling technology to support disease monitoring in patients with acute myeloid leukaemia.

Market | 14/10/2026 | By News Bureau

Biocon Secures Early Launch Dates for Pebrilzo Biosimilar

Biocon has secured the earliest licensed launch dates for Pebrilzo (bPertuzumab) following global patent settlement with Genentech.

Market | 14/10/2026 | By News Bureau

NuSynth Technologies Raises INR 36.5 Crore in Seed Funding

NuSynth Technologies has raised INR 36.5 crore in seed funding co-led by Avaana Capital and Shastra VC to build an R&D-led platform for complex chemistry innovation.

Market | 14/10/2026 | By News Bureau

Catalent and Mantra Sign Oral Gel Supply Agreement

Catalent has partnered with Mantra on oral gel supply, providing formulation development and commercial manufacturing and packaging.

Market | 14/10/2026 | By News Bureau

Agenus Wins First Global Approvals for Botvymo and Evamplix

Armenia has authorised botensilimab and balstilimab for adults with previously treated microsatellite-stable metastatic colorectal cancer without active liver metastases.

Market | 12/10/2026 | By News Bureau |  206

Eli Lilly Reports Biomarker Changes With Taltz-Zepbound Combination

Eli Lilly has reported broader immune, inflammatory and metabolic biomarker changes with Taltz and Zepbound compared with Taltz alone in the TOGETHER-PsO trial.

Market | 12/10/2026 | By News Bureau |  200